NuScale Power (SMR) Is Down 7.4% After Project Delays And Rising Execution Risks Question Deployment Timeline

NuScale Power

NuScale Power

SMR

0.00

  • In recent days, NuScale Power has faced heightened scrutiny as investors reacted to project delays, significant operating losses, and uncertainty around when its NRC-approved small modular reactors will reach full commercial deployment, despite a new exclusive global commercialization partnership with ENTRA1 Energy.
  • This tension between NuScale’s leading regulatory position in small modular reactors and rising execution risks is prompting a broad reassessment of how quickly its technology can translate into meaningful revenues.
  • With concerns about project delays now front and center, we’ll examine how this development could reshape NuScale Power’s investment narrative and risk profile.

The future of work is here. Discover the 30 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

NuScale Power Investment Narrative Recap

To own NuScale Power today, you need to believe that its NRC-approved small modular reactor design and pipeline with partners like ENTRA1 can eventually turn minimal current revenue and large losses into a viable commercial business. The recent share price drop on project delays and cost concerns directly challenges the near term catalyst of converting ENTRA1 opportunities into signed, revenue generating deployments, while also reinforcing the biggest current risk around timing, cash burn, and potential further dilution.

Against that backdrop, the exclusive global commercialization partnership with ENTRA1 Energy is especially important, as it ties NuScale’s technology to a defined development and customer acquisition pathway, including the TVA linked program targeting up to 6 GW. This partnership sits at the heart of both the bullish case for multi decade volume and the key execution risks, since any further delay or slippage in ENTRA1 led projects could materially affect when, and if, NuScale’s reactors translate into substantial revenues.

Yet beneath the promise of ENTRA1’s multi gigawatt ambitions, investors also need to be aware that...

NuScale Power's narrative projects $389.8 million revenue and $42.8 million earnings by 2029.

Uncover how NuScale Power's forecasts yield a $15.36 fair value, a 70% upside to its current price.

Exploring Other Perspectives

SMR 1-Year Stock Price Chart
SMR 1-Year Stock Price Chart

Before this setback, the most optimistic analysts were assuming revenue could reach about US$941.3 million by 2028, so compared with today’s project delay concerns, you can see how sharply views can diverge and why it is worth exploring several different scenarios for NuScale’s future.

Explore 20 other fair value estimates on NuScale Power - why the stock might be worth less than half the current price!

The Verdict Is Yours

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

  • A great starting point for your NuScale Power research is our analysis highlighting 1 key reward and 3 important warning signs that could impact your investment decision.
  • Our free NuScale Power research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate NuScale Power's overall financial health at a glance.

No Opportunity In NuScale Power?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

  • AI is about to change healthcare. These 41 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
  • This technology could replace computers: discover 26 stocks that are working to make quantum computing a reality.
  • Invest in the nuclear renaissance through our list of 89 elite nuclear energy infrastructure plays powering the global AI revolution.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.